Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting
Surface Metals Inc. Expands Land Holdings in Advance of Drilling Campaign at Cimarron Gold Project, Nevada
QIMC Intersects Major Fault Breccia System in DDH-26-03 at West Advocate and Reports Elevated Hydrogen 2.5 km from the Initial Discovery
